Relafen Ds Drug Interactions: 23 Major, 463 Moderate
Relafen Ds (Nabumetone) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Relafen Ds. Always confirm against the full prescribing information.
100 interactions
Abatacept
The metabolism of Nabumetone can be increased when combined with Abatacept.
Level 1 evidence
Acebutolol
Nabumetone may decrease the antihypertensive activities of Acebutolol.
Level 1 evidence
Aceclofenac
The risk or severity of adverse effects can be increased when Nabumetone is combined with Aceclofenac.
Level 1 evidence
Acenocoumarol
The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Acenocoumarol.
Level 1 evidence
Acetaminophen
The risk or severity of adverse effects can be increased when Acetaminophen is combined with Nabumetone.
Level 1 evidence
Acoramidis
The metabolism of Nabumetone can be decreased when combined with Acoramidis.
Level 2 evidence
Acyclovir
The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Acyclovir.
Level 2 evidence
Adagrasib
The metabolism of Nabumetone can be decreased when combined with Adagrasib.
Level 2 evidence
Adalimumab
The metabolism of Nabumetone can be increased when combined with Adalimumab.
Level 1 evidence
Adefovir dipivoxil
The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Adefovir dipivoxil.
Level 2 evidence
Alendronic acid
The risk or severity of adverse effects can be increased when Nabumetone is combined with Alendronic acid.
Level 2 evidence
Aliskiren
The risk or severity of renal failure and hypertension can be increased when Nabumetone is combined with Aliskiren.
Level 1 evidence
Enter your NPI to unlock 3 major interactions for Relafen Ds
Relafen Ds (Nabumetone) has 949 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Relafen Ds (Nabumetone) has 23 major, 463 moderate, and 463 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Relafen Ds. Always confirm against the full prescribing information.